06.07.2016 09:45:11
|
DGAP-Stimmrechtsanteile: Vita 34 AG
DGAP-PVR: Vita 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
3. Details of person subject to the notification obligation
Name: City and country of registered office: Human Stem Cells Institute Moscow Russian Federation PJSC
4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.
5. Date on which threshold was crossed or reached
28 Jun 2016
6. Total positions
% of voting % of voting rights total of total number rights attached through instruments both in % of voting to shares (total (total of 7.b.1 + (7.a. + rights of of 7.a.) 7.b.2) 7.b.) issuer Result- 5.50 % 3.96 % 9.47 % 3026500 ing situat- ion Previo- 8.57 % % % / us notifi- cation
7. Notified details of the resulting situation a. Voting rights attached to shares (Sec.s 21, 22 WpHG)
ISIN absolute in % direct indirect direct indirect (Sec. 21 WpHG) (Sec. 22 WpHG) (Sec. 21 WpHG) (Sec. 22 WpHG) DE000A0BL849 166607 5.50 % % Total 166607 5.50 %
b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG
Type of Expiration or Exercise or Voting Voting instrument maturity date conversion rights rights in period absolute % Repurchase 29.03.2017 120000 3.96 % agreement Total 120000 3.96 %
b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG
Type of Expiration Exercise or Cash or Voting Voting instrume- or maturity conversion physical rights rights nt date period settlement absolute in % % Total %
8. Information in relation to the person subject to the notification obligation
X Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:
Name % of voting rights % of voting rights Total of both (if (if at least held 3% through instruments (if at least held 5% or more) at least held 5% or more) or more)
9. In case of proxy voting according to Sec. 22 para. 3 WpHG
Date of general meeting: Holding position after general meeting: % (equals voting rights)
10. Other explanatory remarks:
06.07.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
--------------------------------------------------------------------------- Language: English Company: Vita 34 AG Deutscher Platz 5a 04103 Leipzig Germany Internet: www.vita34.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------
Vita 34 AG
06.07.2016 09:45
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Notification of Major Holdings
1. Details of issuer
Vita 34 AG
Deutscher Platz 5a
04103 Leipzig
Germany
2. Reason for notification
X Acquisition/disposal of shares with voting rights
Acquisition/disposal of instruments
Change of breakdown of voting rights
Other reason:
3. Details of person subject to the notification obligation
Name: City and country of registered office: Human Stem Cells Institute Moscow Russian Federation PJSC
4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.
5. Date on which threshold was crossed or reached
28 Jun 2016
6. Total positions
% of voting % of voting rights total of total number rights attached through instruments both in % of voting to shares (total (total of 7.b.1 + (7.a. + rights of of 7.a.) 7.b.2) 7.b.) issuer Result- 5.50 % 3.96 % 9.47 % 3026500 ing situat- ion Previo- 8.57 % % % / us notifi- cation
7. Notified details of the resulting situation a. Voting rights attached to shares (Sec.s 21, 22 WpHG)
ISIN absolute in % direct indirect direct indirect (Sec. 21 WpHG) (Sec. 22 WpHG) (Sec. 21 WpHG) (Sec. 22 WpHG) DE000A0BL849 166607 5.50 % % Total 166607 5.50 %
b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG
Type of Expiration or Exercise or Voting Voting instrument maturity date conversion rights rights in period absolute % Repurchase 29.03.2017 120000 3.96 % agreement Total 120000 3.96 %
b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG
Type of Expiration Exercise or Cash or Voting Voting instrume- or maturity conversion physical rights rights nt date period settlement absolute in % % Total %
8. Information in relation to the person subject to the notification obligation
X Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:
Name % of voting rights % of voting rights Total of both (if (if at least held 3% through instruments (if at least held 5% or more) at least held 5% or more) or more)
9. In case of proxy voting according to Sec. 22 para. 3 WpHG
Date of general meeting: Holding position after general meeting: % (equals voting rights)
10. Other explanatory remarks:
06.07.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
--------------------------------------------------------------------------- Language: English Company: Vita 34 AG Deutscher Platz 5a 04103 Leipzig Germany Internet: www.vita34.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!